Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study

06 January 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Peptide-based therapeutics are increasingly coming to the forefront of biomedicine with their promise of high specificity and low toxicity. Although noncanonical residues can always be used, employing only the natural 20 residues restricts the chemical space to a finite dimension allowing for comprehensive in silico screening. Towards this goal, the dataset comprising all possible di, tri, and tetrapeptide combinations of the canonical residues has been previously reported. However, with increasing computational power, the comprehensive set of pentapeptides are now also feasible for screening as are the comprehensive set of cyclic peptides comprising four or five residues. Here, we provide both the complete and prefiltered libraries of all di, tri, tetra, and pentapeptide sequences from 20 canonical amino acids and their homodetic (N-to-C-terminal) cyclic homologues. The libraries in the FASTA, SMILES, and SDF-3D formats can be readily used for screening against protein targets. Access to this dataset will accelerate small peptide screening workflows and encourage their use in drug discovery campaigns. As a case study, the developed library was screened against SARS-CoV-2 Mpro to identify potential small peptide inhibitors.

Keywords

peptide
library
high throughput
cyclic peptides
SARS-CoV-2
Virtual screen

Supplementary materials

Title
Description
Actions
Title
Sample list of pentapeptides
Description
Manipulatable excel file with a sample of the pentapeptides for trial filtering. Full files available in the online repositories.
Actions
Title
Supporting information
Description
Additional images and analyses of the case studies in the main article
Actions

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.